DexCom faces challenges in 2024 due to competition and missteps, but the long-term outlook for continuous glucose monitors ...

Medical device specialist DexCom (NASDAQ: DXCM) is going through a rough patch. The company's shares are down sharply year to date due to unimpressive financial results -- and some of the ...

Dexcom's CGM and Abbott's FreeStyle Libre are ... CGMs that require the CGM to be scanned often to view and store data ...

Dexcom Vice President Columba McGarvey said ... “In the past five years, Penang recorded exports of RM149 billion in professional, scientific, and controlling instruments, which accounts for ...

DexCom's devices are incredibly valuable to diabetes patients. The company should continue to increase its addressable market. The stock's valuation looks as reasonable as it has in almost three ...

Investing.com -- DexCom Inc (NASDAQ:DXCM) shares up more than 2% following updated guidelines by the American Diabetes Association (ADA), which now recommend using continuous glucose monitors ...

Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom. The investment marks Oura’s Series D funding round and brings the ...

Carillon Eagle Mid Cap Growth Fund highlighted stocks like DexCom, Inc. (NASDAQ:DXCM), in the third quarter 2024 investor letter. DexCom, Inc. (NASDAQ:DXCM) is a medical device company that ...

Dexcom has seen the potential in combining ... whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from ...